BioCentury
ARTICLE | Clinical News

Tianeptine: Interim Phase IIa data

February 24, 2014 8:00 AM UTC

Interim data from the first cohort of 8 healthy volunteers receiving infusions of alfentanil in a double-blind, placebo-controlled, crossover, Dutch Phase IIa trial showed that 37.5 mg REV-001 was saf...